The Lancet infectious diseases

(ISSN: 1473-3099, 1474-4457)

Table of Contents

2015 - 15 (12)

  • Abdominal cocoon syndrome caused by Mycobacterium bovis from consumption of unpasteurised cow's milk. 
  • Miliary tuberculosis characterised by lipomembranous fat necrosis. 
  • Extensively drug-resistant tuberculosis in a young child after travel to India. 
  • Infectious disease surveillance update. 
  • Phage therapy for severe infections tested in the first multicentre trial. 
  • Honouring pioneers of treatments for malaria and nematode infections. 
  • Mission Indradhanush and the counterfeit drug trade in India. 
  • Hepatitis C virus genotype 1 NS5A variants in Japanese patients. 
  • Schistosomiasis in Corsica and the pivotal role of travellers. 
  • HIV and hepatitis C virus co-infection in Kenya. 
  • How many patients with anti-JEV IgM in cerebrospinal fluid really have Japanese encephalitis? 
  • Innovative Medicines Initiative and antibiotic resistance. 
  • Tuberculosis reaches new milestones, good and bad. 
  • Benefits of combined preventive therapy with co-trimoxazole and isoniazid in adults living with HIV: time to consider a fixed-dose, single tablet coformulation. 
  • Typing of Neisseria meningitidis by whole-genome analysis. 
  • Genomic epidemiology of age-associated meningococcal lineages in national surveillance: an observational cohort study. 
  • Respiratory syncytial virus trials and beyond. 
  • Efficacy of motavizumab for the prevention of respiratory syncytial virus disease in healthy Native American infants: a phase 3 randomised double-blind placebo-controlled trial. 
  • Antibiotic resistance threatens the efficacy of prophylaxis. 
  • Potential burden of antibiotic resistance on surgery and cancer chemotherapy antibiotic prophylaxis in the USA: a literature review and modelling study. 
  • Emerging tick-borne infections in mainland China: an increasing public health threat. 
  • Putting your money where your mouth is: Scotland's attack on MRSA pays off. 
  • Effects of national antibiotic stewardship and infection control strategies on hospital-associated and community-associated meticillin-resistant Staphylococcus aureus infections across a region of Scotland: a non-linear time-series study. 
  • High-dose influenza vaccines make economic sense for older people. 
  • Cost-effectiveness of high-dose versus standard-dose inactivated influenza vaccine in adults aged 65 years and older: an economic evaluation of data from a randomised controlled trial. 
  • Ferroquine and artesunate in African adults and children with Plasmodium falciparum malaria: a phase 2, multicentre, randomised, double-blind, dose-ranging, non-inferiority study. 
  • Ferroquine: welcome to the next generation of antimalarials. 
  • Antibody titre as a surrogate of protection of the first malaria subunit vaccine, RTS,S/AS01. 
  • Immunogenicity of the RTS,S/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trial. 
  • Neonatal rotavirus vaccination making headway. 
  • Safety and immunogenicity of RV3-BB human neonatal rotavirus vaccine administered at birth or in infancy: a randomised, double-blind, placebo-controlled trial. 
  • Emergence of whooping cough: notes from three early epidemics in Persia. 
All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.